Clinical Trial

Use of a Taurolidine Containing Antimicrobial Wash to Reduce Prosthetic Device Infection After Trauma Surgery

Study acronym: Prosafeti
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A taurolidine-based antimicrobial solution, was evaluated for its safety and efficacy in preventing infections associated with prosthetic materials, such as joint replacements, plates, nails, and screws. This prospective observational study compared Taurolidine to infection rates from scientific literature.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-08.
Trial Details
NCT Number NCT06919770
Lead Sponsor University of Kiel
Conditions Osteosynthesis, Infection Prevention
Enrollment 28 participants
Start Date 2022-01-01
Primary Completion 2030-07-30 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-20